- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Syschem India Limited reported softer financial performance for the second quarter, experiencing revenue moderation and a net deficit, primarily due to foreign exchange fluctuations and global market volatility. Despite these challenges, the company maintained strong operational efficiency, controlled expenses, and stable cash flow. Management focuses on operational excellence, cost optimization, and market strengthening. The company is expanding manufacturing capacity for key products like Amoxicillin and working towards WHO-GMP certification. It also highlighted workforce growth, geographic expansion, and ESG initiatives for sustainability.